Polymorphic variants in the p53 pathway

Cell Death and Differentiation

Volumn 13, Issue 6, 2006, Pages 916-920

  Murphy, Maureen E ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; PROTEIN MDM2; PROTEIN P53;

BINDING SITE; CANCER GROWTH; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; CODON; COLORECTAL CANCER; GENE FREQUENCY; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEAD AND NECK CARCINOMA; HOMOZYGOSITY; HUMAN; LEUKOCYTE; NOTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; SQUAMOUS CELL CARCINOMA;

ANIMALS; DNA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC; PROTO-ONCOGENE PROTEINS C-MDM2; TRANS-ACTIVATION (GENETICS); TRANSCRIPTIONAL ACTIVATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33646788452     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4401907     Document Type: Note

References (50)

1. Matlashewski G et al. (1984) EMBO J. 3: 3257-3262.
2. Wolf D, Laver-Rudich Z and Rotter V (1985) Mol. Cell. Biol. 5: 1887-1893.
3. Harlow E et al. (1985) Mol. Cell. Biol. 5: 1601-1610.
4. Matlashewski GJ et al. (1987) Mol. Cell. Biol. 7: 961-963.
5. Buchman VL et al. (1988) Gene 70: 245-252.
6. Ara S et al. (1990) Nucleic Acids Res. 18: 4961.
7. Beckman G et al. (1994) Hum. Hered. 44: 266-270.
8. Thomas M et al. (1999) Mol. Cell. Biol. 19: 1092-1100.
9. Storey A et al. (1998) Nature 393: 229-234.
10. Bonafe M et al. (2002) Biochem. Biophys. Res. Commun. 299: 539-541.
11. Dumont P et al. (2003) Nat. Genet. 33: 357-365.
12. Marchenko ND, Zaika A and Moll UM (2000) J. Biol. Chem. 275: 16202-16212.
13. Boyd SD, Tsai KY and Jacks T (2000) Nat. Cell Biol. 2: 563-568.
14. Geyer RK, Yu ZK and Maki CG (2000) Nat. Cell Biol. 2: 569-573.
15. Leu JI et al. (2004) Nat. Cell Biol. 6: 443-450.
16. Hsu YT and Youle RJ (1997) J. Biol. Chem. 272: 13829-13834.
17. Chipuk JE et al. (2004) Science 303: 1010-1014.
18. Mihara M et al. (2004) Mol. Cell. 11: 577-590.
19. Sjalander A et al. (1996) Carcinogenesis 17: 1313-1316.
20. Wu X et al. (2002) J. Natl. Cancer Inst. 94: 681-690.
21. Granja F et al. (2004) Cancer Lett. 210: 151-157.
22. Weston A et al. (1994) Carcinogenesis 15: 583-587.
23. Birgander R et al. (1995) Carcinogenesis 16: 2233-2236.
24. Rosenthal A et al. (1998) Lancet 352: 871-872.
25. Jones JS et al. (2004) Clin. Cancer Res. 10: 5845-5849.
26. Shen H et al. (2002) Cancer Lett. 183: 123-130.
27. Sullivan A et al. (2004) Oncogene 23: 3328-3337.
28. Felley-Bosco E et al. (1993) Am. J. Hum. Genet. 53: 752-759.
29. Li X et al. (2005) J. Biol. Chem. 280: 24245-24251.
30. Bond GL et al. (2004) Cell 119: 591-602.
31. Arva NC et al. (2005) J. Biol. Chem. 280: 26776-26787.
32. Oliner JD et al. (1993) Nature 362: 857-860.
33. Bougeard G et al. (2005) J. Med. Genet. [E-pub ahead of print].
34. Hong Y et al. (2005) Cancer Res. 65: 9582-9587.
35. Swinney RM et al. (2005) Leukemia 19: 1996-1998.
36. Zhang X et al. (2005) Hum. Mutat. [E-pub ahead of print].
37. Alhopuro P et al. (2005) J. Med. Genet. 42: 694-698.
38. Campbell IG, Eccles DM and Choong DY (2005) Cancer Lett. [E-pub ahead of print].
39. Hu Z et al. (2006) Int. J. Cancer 118: 1275-1278.
40. Ma H et al. (2005) Cancer Lett. [E-pub ahead of print].
41. Inga A et al. (2002) Mol. Cell. Biol. 22: 8612-8625.
42. el-Deiry WS et al. (1992) Nat. Genet. 1: 45-49.
43. Tomso DJ et al. (2005) Proc. Natl. Acad. Sci. USA 102: 6431-6436.
44. van Heemst D et al. (2005) Exp. Gerontol. 40: 11-15.
45. Tyner SD et al. (2002) Nature 415: 45-53.
46. McGregor JM et al. (2002) J. Invest. Dermatol. 119: 84-90.
47. Su L et al. (2003) Lung Cancer 40: 259-266.
48. Bahl R et al. (2000) Oncogene 19: 323-328.
49. Ralhan R et al. (2000) Clin. Cancer Res. 6: 2440-2447.
50. Contente A et al. (2002) Nat. Genet. 30: 315-320.